These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23629660)

  • 21. Roles of N-terminal active cysteines and C-terminal cysteine-selenocysteine in the catalytic mechanism of mammalian thioredoxin reductase.
    Fujiwara N; Fujii T; Fujii J; Taniguchi N
    J Biochem; 2001 May; 129(5):803-12. PubMed ID: 11328605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of metals in hypothiocyanite resistance in
    Gray MJ
    J Bacteriol; 2024 Aug; 206(8):e0009824. PubMed ID: 39016617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
    Fang J; Holmgren A
    J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
    Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
    Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
    Lu J; Vlamis-Gardikas A; Kandasamy K; Zhao R; Gustafsson TN; Engstrand L; Hoffner S; Engman L; Holmgren A
    FASEB J; 2013 Apr; 27(4):1394-403. PubMed ID: 23248236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative reactivity of the myeloperoxidase-derived oxidants hypochlorous acid and hypothiocyanous acid with human coronary artery endothelial cells.
    Lloyd MM; Grima MA; Rayner BS; Hadfield KA; Davies MJ; Hawkins CL
    Free Radic Biol Med; 2013 Dec; 65():1352-1362. PubMed ID: 24120969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase.
    Hashemy SI; Ungerstedt JS; Zahedi Avval F; Holmgren A
    J Biol Chem; 2006 Apr; 281(16):10691-7. PubMed ID: 16481328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
    Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
    Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can Selenoenzymes Resist Electrophilic Modification? Evidence from Thioredoxin Reductase and a Mutant Containing α-Methylselenocysteine.
    Ste Marie EJ; Wehrle RJ; Haupt DJ; Wood NB; van der Vliet A; Previs MJ; Masterson DS; Hondal RJ
    Biochemistry; 2020 Sep; 59(36):3300-3315. PubMed ID: 32845139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate specificity of the mitochondrial thioredoxin reductase of the parasitic nematode Haemonchus contortus.
    Hudson AL; Sotirchos IM; Davey MW
    Parasitol Res; 2010 Jul; 107(2):487-93. PubMed ID: 20495929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the myeloperoxidase-derived oxidant hypothiocyanous acid (HOSCN) in the induction of mitochondrial dysfunction in macrophages.
    Love DT; Guo C; Nikelshparg EI; Brazhe NA; Sosnovtseva O; Hawkins CL
    Redox Biol; 2020 Sep; 36():101602. PubMed ID: 32570189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidation of 2-cys peroxiredoxins in human endothelial cells by hydrogen peroxide, hypochlorous acid, and chloramines.
    Stacey MM; Vissers MC; Winterbourn CC
    Antioxid Redox Signal; 2012 Aug; 17(3):411-21. PubMed ID: 22229717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selenocysteine confers resistance to inactivation by oxidation in thioredoxin reductase: comparison of selenium and sulfur enzymes.
    Snider GW; Ruggles E; Khan N; Hondal RJ
    Biochemistry; 2013 Aug; 52(32):5472-81. PubMed ID: 23865454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
    Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
    Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth.
    Johnson SS; Liu D; Ewald JT; Robles-Planells C; Pulliam C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Menda Y; Spitz DR; Fath MA
    Cancer Biol Ther; 2024 Dec; 25(1):2382524. PubMed ID: 39054566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thioredoxin reductase.
    Mustacich D; Powis G
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):1-8. PubMed ID: 10657232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of endogenous antioxidants with Auranofin causes mitochondrial oxidative stress which can be countered by selenium supplementation.
    Radenkovic F; Holland O; Vanderlelie JJ; Perkins AV
    Biochem Pharmacol; 2017 Dec; 146():42-52. PubMed ID: 28947276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.